Alogliptin Benzoate

Overview

Alogliptin Benzoate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL227529).

API suppliers (2)

Suppliers of Alogliptin Benzoate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Ono Pharmaceutical Co., Ltd.Japan2 active DMF
• HONOUR LAB LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (3 approved US products), the latest listed US patent on Alogliptin Benzoate expires 15 Jun 2029 and exclusivity 26 Jul 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile;benzoic acid

Canonical SMILES

CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N.C1=CC=C(C=C1)C(=O)O

InChIKey

KEJICOXJTRHYAK-XFULWGLBSA-N